In August 2010, the FDA recalled over 90,000 DePuy hip implants. The recall included two models, the ASR XL Acetabular System and the ASR Hip Resurfacing System manufactured by Johnson & Johnson and DePuy Orthopedics. The FDA has acknowledged a design flaw in the hip implants, which made them difficult to implant. According to the FDA, the ASR cup in the implants is too shallow compared to other devices currently on the market. Therefore, DePuy and Johnson & Johnson were forced to recall approximately 93,000 hip implants, opening the door for an influx of lawsuits.

This design flaw has led to a series of adverse side effects and complications often prompting the need for a revision surgery soon after the initial implant. For approximately 1 out of every 8 patients with the DePuy hip implant, the severe side effects have resulted in an additional surgery. Metal particles from the hip implants can break off and enter a person’s bloodstream creating pseudotumors and other adverse reactions. Also, the metal cap attached to the femur can come loose resulting in dislocation or fracture. Due to the frequency of these complications, people across the nation are alleging that DePuy Orthopedics and Johnson & Johnson failed to adequately research and test the implant and prematurely put it on the market.

This recall has paved the way for those suffering from adverse side effects to file lawsuits against DePuy Orthopedics and Johnson & Johnson. If you or someone you know has suffered any of these adverse side effects or needed an additional surgery to fix a defect, contact the defective device attorneys at Arias, Ozzello & Gignac today. You may be entitled to compensation for your damages. Contact us for a free consultation.